1 Duntas LH, "There is no 'universal fit': Reflections on the use of l-triiodothyronine in the treatment of hypothyroidism" 65 (65): 428-431, 2016
2 Wiersinga WM, "THERAPY OF ENDOCRINE DISEASE: T4+ T3 combination therapy: Is there a true effect?" 177 (177): R287-R296, 2017
3 Hoermann R, "Relational stability of thyroid hormones in euthyroid subjects and patients with autoimmune thyroid disease" 5 (5): 171-179, 2016
4 Kelderman-Bolk N, "Quality of life in patients with primary hypothyroidism related to BMI" 173 (173): 507-515, 2015
5 Wiersinga WM, "Paradigm shifts in thyroid hormone replacement therapies for hypothyroidism" 10 (10): 164-174, 2014
6 Gullo D, "Levothyroxine monotherapy cannot guarantee euthyroidism in all athyreotic patients" 6 (6): e22552-, 2011
7 Hoermann R, "Is pituitary TSH an adequate measure of thyroid hormone-controlled homoeostasis during thyroxine treatment?" 168 (168): 271-280, 2013
8 Peterson SJ, "Is a Normal TSH synonymous with "euthyroidism" in levothyroxine monotherapy?" 101 (101): 4964-4973, 2016
9 Hoermann R, "Homeostatic equilibria between free thyroid hormones and pituitary thyrotropin are modulated by various influences including age, body mass index and treatment" 81 (81): 907-915, 2014
10 Jonklaas J, "Guidelines for the treatment of hypothyroidism:Prepared by the american thyroid association task force on thyroid hormone replacement" 24 (24): 1670-1751, 2014
1 Duntas LH, "There is no 'universal fit': Reflections on the use of l-triiodothyronine in the treatment of hypothyroidism" 65 (65): 428-431, 2016
2 Wiersinga WM, "THERAPY OF ENDOCRINE DISEASE: T4+ T3 combination therapy: Is there a true effect?" 177 (177): R287-R296, 2017
3 Hoermann R, "Relational stability of thyroid hormones in euthyroid subjects and patients with autoimmune thyroid disease" 5 (5): 171-179, 2016
4 Kelderman-Bolk N, "Quality of life in patients with primary hypothyroidism related to BMI" 173 (173): 507-515, 2015
5 Wiersinga WM, "Paradigm shifts in thyroid hormone replacement therapies for hypothyroidism" 10 (10): 164-174, 2014
6 Gullo D, "Levothyroxine monotherapy cannot guarantee euthyroidism in all athyreotic patients" 6 (6): e22552-, 2011
7 Hoermann R, "Is pituitary TSH an adequate measure of thyroid hormone-controlled homoeostasis during thyroxine treatment?" 168 (168): 271-280, 2013
8 Peterson SJ, "Is a Normal TSH synonymous with "euthyroidism" in levothyroxine monotherapy?" 101 (101): 4964-4973, 2016
9 Hoermann R, "Homeostatic equilibria between free thyroid hormones and pituitary thyrotropin are modulated by various influences including age, body mass index and treatment" 81 (81): 907-915, 2014
10 Jonklaas J, "Guidelines for the treatment of hypothyroidism:Prepared by the american thyroid association task force on thyroid hormone replacement" 24 (24): 1670-1751, 2014
11 Jeon MJ, "Excessive iodine intake and thyrotropin reference interval:Data from the Korean National Health and Nutrition examination survey" 27 (27): 967-972, 2017
12 Panicker V, "Common variation in the DIO2 gene predicts baseline psychological well-being and response to combination thyroxine plus triiodothyronine therapy in hypothyroid patients" 94 (94): 1623-1629, 2009
13 Garber JR, "Clinical practice guidelines for hypothyroidism in adults: Cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association" 22 (22): 1200-1235, 2012
14 Ito M, "Biochemical markers reflecting thyroid function in athyreotic patients on levothyroxine monotherapy" 27 (27): 484-490, 2017
15 Koo TK, "A guideline of selecting and reporting intraclass correlation coefficients for reliability research" 15 (15): 155-163, 2016
16 Wiersinga WM, "2012 ETA guidelines: The use of L-T4 +L-T3 in the treatment of hypothyroidism" 1 (1): 55-71, 2012